Podcasts about early diagnosis

In this powerful episode, host Rashidah sits down with Karidiatou Coulibaly (known as Kadi), founder of Moussa Unfolded Hope Initiative (MUHI), to discuss her family's autism journey and the unique challenges many African families face when navigating disability, stigma, and cultural expectations.Raised in an African community where autism was rarely discussed, Karidiatou found herself searching for answers after her son, Moussa, was diagnosed with Autism Spectrum Disorder. What followed was a journey of learning, advocacy, and a commitment to changing how autism is understood within African communities.Together, they explore the impact of cultural beliefs, the silence that often surrounds disability, and the importance of representation, awareness, and acceptance.About Our GuestKaridiatou Coulibaly is the founder of Moussa Unfolded and the Moussa Unfolded Hope Initiative, a nonprofit dedicated to supporting families and transforming how autism is understood within African communities. Originally from Ivory Coast (West Africa), Kadi came to the United States with little knowledge of autism — because in her community, it simply wasn't talked about.She holds a bachelor's degree in agribusiness economics and a master's degree in Applied Behavior Analysis (ABA). She is also developing a children's animated series titled, "The Land Where We Speak", designed to represent children with diverse disabilities and teach inclusivity through storytelling.Karidiatou resides in Georgia with her familyConnect with Karidiatou:Instagram: www.instagram.com/moussa_unfoldedTikTok: moussa_unfolded13In this episode, we discuss:0:00 – Welcome0:42 – Episode Overview1:12 – Autism Stigma in African Communities2:06 – Meet Karidiatou Coulibaly 3:31 – The Conversation Begins4:08 – Musa Turns 135:11 – Karidiatou's Story5:28 – Moussa's Early Diagnosis 7:18 – Cultural Barriers: being from the African diaspora8:30 – Karidiatou Never Hides Autism14:19 – Karidiatou's Hearing Loss Journey20:49 – Moussa's Growth & Independence22:56 – Building Daily Life Skills27:45 – Returning to School30:05 – The Story Behind Moussa Unfolded34:03 – Supporting Other Moms47:14 – What makes Karidiatou a Badass Mom?If this episode resonated with you:-Follow the Autism for Badass Moms Podcast on your favorite platform-Leave a review to help other autism moms find this community-Share this episode with a parent who may feel unseen or misunderstoodInstagram: www.instagram.com/theabmpodcastFacebook: www.facebook.com/theabmpodcastJoin us every Tuesday for more inspiring stories and insightful discussions that empower and uplift.

This week, Bobbi Conner talks with MUSC's Dr. Nicholas Milano about the importance of early diagnosis and treatment of Alzheimer's disease.

Today, we're speaking to Dr Garth Funston, a GP and Clinical Senior Lecturer in Primary Care Cancer Research at Queen Mary University of London. Title of paper: Using large language models to identify pre-diagnostic clinical features of ovarian cancer from healthcare records: a population-based case-control studyAvailable at: https://doi.org/10.3399/BJGP.2025.0366Most women with ovarian cancer present with symptoms, but many symptoms are recorded only in free text healthcare records and missed by studies and clinical decision support tools that rely on coded data. We found that using large language models (LLMs) to extract symptoms from free text records substantially increased symptom detection and strengthened associations with ovarian cancer. Incorporating LLM-extracted symptom information into research and clinical decision tools may support identification of women at higher risk of cancer and aid appropriate investigation.TranscriptThis transcript was generated using AI and has not been reviewed for accuracy. Please be aware it may contain errors or omissions.Speaker A00:00:00.800 - 00:00:50.940Hi and welcome to BJGP Interviews. I'm Nada Khan and I'm one of the Associate editors of the Journal. Thanks for listening to this podcast today.In today's episode, we're talking to Dr. Garth Funston, who is an academic GP and clinical senior Lecturer in Primary Care Research at Queen Mary University of London.We're here to talk about his recent paper in the BJDP which is titled Using Large Language Models to Identify Pre Diagnostic Clinical Features of Ovarian and Cancer from Healthcare Records.So, Garth, thanks so much for talking to us again today, but I wonder, just before we get into the AI side of this paper, can you briefly explain the clinical problem you're trying to address here with ovarian cancer diagnosis in general practice?Speaker B00:00:51.500 - 00:01:55.010So most women with ovarian cancer are diagnosed after they develop symptoms and see their doctor. The challenge is that most symptoms are really non specific. There's no real red flag symptoms for ovarian cancer.That makes it a real clinical challenge for the GP to kind of recognize it and perform tests.So the symptoms are things like abdominal and pelvic pain, persistent bloating, urinary urgency and frequency, things that we see really frequently in gp. So knowing when to consider ovarian cancer is the big challenge.And we know that certainly a proportion of women see their GP multiple times before the diagnosis. Now we're lucky for ovarian cancer in that we have reasonably good triage tests and CA125 and transvaginal ultrasound.So the challenge really is to identify women with these non specific symptoms early so as we can work out who to test and hopefully improve early diagnosis and on outcomes in that way.Speaker A00:01:55.250 - 00:02:14.530Yeah, and I'm sure you're well aware of sort of the body work around this area and people like Willie Hamilton, who's done work around early diagnosis of ovarian cancer, along with Claire Bankhead, and they did some really interesting work around things like bloating, didn't they? But that was slightly different, I think, and a little bit that's some time ago now, isn't it?Speaker B00:02:14.930 - 00:02:39.230Yeah, it was some time ago. I think all of that is, you know, fundamental and still holds true.And they did a lot of work around things like IBS and in women over, over 50 and things like that that are kind of these subtle signs that we need to be aware of with ovarian cancer.So, yeah, we know there's lots of features that are associated with ovarian cancer, but it's recognizing when to invest to get those features because they're so common.Speaker A00:02:39.630 - 00:02:49.310Yeah. And do you think that's why it's described as difficult to diagnose early in general practice? Is it because the symptoms are so common?What are your thoughts on that?Speaker B00:02:49.390 - 00:03:48.750I think there's a few reasons.I think ovarian cancer used to be called, certainly in the media, the kind of the silent killer and terminology, which I really, really frustrates me, because we know it's not. We know that most women of symptoms for diagnosis. We actually know that from this paper and other papers that are symptoms in early stage cancer.But that kind of thought around ovarian cancer still holds. Secondly, the symptoms are nonspecific, they're reasonably common. I mean, you know, I probably see a.A patient with abdominal pain most days and it's kind of working out which ones to investigate for ovarian cancer. Yeah. And so I think those are the main things. And thirdly, it's, you know, it's not the most common common cancer.GP will see people probably only encounter a case of ovarian cancer every three to five years, a new case. And that's the extra challenge. It's kind of suspecting it when it's a rare thing in primary care.Speaker A00:03:49.100 - 00:04:03.500Yeah. And one thing I found really interesting about this work is that you're using free text clinical records rather than just coded data.So can you tell us a little bit about the data you accessed here and why it was so important to use this free text data?Speaker B00:04:04.220 - 00:05:09.600So a lot of the work that we do with primary care data focuses on coded data and certainly within the uk, because that's really the data we can actually access within UK for research purposes. But up to 80% of clinical information is not in that coded format, it's in the free text.And work from people like Sarah Price in the past have shown that often subtle things that we need to pick up are in the free text and GPS don't code that.So it's something I've been really keen to use in research for many years now to try and look at what extra information is there in the free text that could help us in both research and clinical practice and kind of picking up these cancers. And the data we accessed was from the United States, it was from healthcare clinics associated with the University of Washington.And that included kind of coded data, but also the free text medical records of patients which had been anonymized and were accessed in a kind of a safe and appropriate way.Speaker A00:05:10.000 - 00:05:40.140Yeah.And I think a lot of clinical staff listening to this will certainly, certainly appreciate that a Lot goes into the notes that we just type in that doesn't really get coded. So it's phenomenal that you're able to access that data.And this paper uses large language models or LLMs, which some people might associate, associate with tools like ChatGPT, but just at a very basic level. Can you just talk us through what actually is a large language model and what sort of it was used for in this, in this study?Speaker B00:05:40.950 - 00:06:49.130Large language models, lots of people use them on a daily basis. Absolutely right.Things like ChatGPT, they're essentially a tool for our purposes which we use to extract information from the free text medical records. Now natural language processing approaches have been used actually for many years, kind of rule based approaches.Other models, these require lots of training. You need to lots of highly annotated records and notes to train the models.Advantage of large language models, things like GPT, is they need less annotated notes and we did still do some of that, but they require less and that makes them much easier to apply and use in practice. We use them in this setting to effectively pull out key information on symptoms.We predefined a list of 17 symptoms from the literature which were associated with ovarian cancer and we used the large language models to go through the notes, pull out information on those symptoms that we could use in the study alongside the coded data.Speaker A00:06:50.090 - 00:07:03.350And I think that as we've been discussing, these large language models are probably really useful for this kind of data. I think especially because a lot of general practice is narrative and contextual as we've been discussing as well.Speaker B00:07:03.350 - 00:07:38.940Yeah, I think, I mean there's two challenges with using free text data. One is access requirements because there's lots of concerns around confidentiality. The other is just the volume of it.You've got these massive records that you know, contain lots of information, lots of writing, go back years. How do you actually process that to find the key information that you need?I think large language models are a really useful tool here because with a bit of training you can use them to actually extract the information that's pertinent to your kind of question.Speaker A00:07:39.340 - 00:07:48.620So let's go into what you found and I'm really interested to know about what kind of patterns or features was this model able to identify before an ovarian cancer diagnosis.Speaker B00:07:49.180 - 00:09:06.690So we looked at 17, 17 features. We find actually that 14 of the features were more frequently recorded within the free text and coded...

Drs. Dasgupta and Sarswat review how ATTR cardiomyopathy remains under-recognized despite its prevalence in older patients with heart failure, emphasizing clinical red flags across cardiac and systemic manifestations. They outline a practical diagnostic pathway that prioritizes early identification using light-chain evaluation, bone scintigraphy, and genetic testing to distinguish transthyretin subtypes and initiate timely, disease-modifying therapy.

ThePrintPod: Alzheimer's may show up in blood yrs before symptoms appear—Lancet study offers hope of early diagnosis

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Early Diagnosis of ATTR-CM by Age- and Carpal Tunnel Biopsy-Guided Screening.

The live phone-in programme “Hello Doctor” by the Diabetes Care Foundation of India featured expert guidance from Dr. Sunil Gupta and Dr. Shlok Gupta on diabetes awareness, diagnosis, prevention, and treatment. During the discussion, Dr. Sunil Gupta highlighted the alarming rise of diabetes and prediabetes in India. Referring to recent health data, he explained that nearly every fourth adult above 18 years of age is affected by either diabetes or prediabetes. He emphasized that many people remain undiagnosed for years because diabetes often develops without noticeable symptoms. The experts stressed the importance of regular health check-ups, especially after the age of 35, or earlier in people with a family history of diabetes. They explained the role of HbA1c testing, fasting blood sugar, and oral glucose tolerance tests in diagnosing diabetes and prediabetes. Dr. Gupta also discussed how obesity, genetics, sedentary lifestyle, and poor eating habits increase diabetes risk. He warned against self-medication and explained that diabetes treatment must be individualized based on factors such as body weight, insulin production, and insulin resistance. Dr. Shlok Gupta explained that very high blood sugar levels can temporarily exhaust insulin-producing beta cells. In such cases, short-term insulin therapy may help the pancreas recover before shifting patients back to oral medicines. The programme also highlighted modern diabetes technologies such as Continuous Glucose Monitoring (CGM) systems and insulin pumps, which help patients monitor and control blood sugar more effectively. Expert- Dr Sunil Gupta & Dr Shlok Gupta Anchor- Purva Kulkarni Podcast: 24/04/2026 Recorded at: Akashwani Nagpur

In today's podcast, we'll dive into the personal journeys of two very interesting and accomplished people who have dealt with this disease and will share their experiences, and importantly, their opinions, shedding light on symptoms, diagnosis, the struggles and frustrations, and the importance of awareness to affect early diagnosis and to manage the condition effectively.   I'm delighted to welcome Jonathan Kahan and Darro Chea and bring you this engaging, insightful conversation.  Acromegaly is a complex condition that requires knowledge and understanding. I am very thankful to both Jonathan and Darro for sharing their stories and helping in our mission to help and educate.

What if your "train wreck" 20s and 30s weren't failure at all — just everyone missing your ADHD diagnosis? The Impulsive Thinker® and Dr. Stephen Hinshaw destroy the old stereotypes on women, masking, and why success leaves so many suffering in silence.   In This Episode: What decades-long studies of girls with ADHD actually reveal How masking, missed signs, and stigma sabotage real ADHD Entrepreneur strengths Why negative outcomes are high risk — but not destiny   What You'll Take Away: ADHD in women is missed, not rare — the classic "boy" symptoms don't fit Depression, self-injury, and unplanned chaos spike when diagnosis and support come late Masking isn't resilience — it's losing yourself because fitting in means survival Early signs in girls are spacey, scattered, "lazy," not loud or disruptive Real friends and strategic support matter more than popularity or the perfect image   GUEST BIO Dr. Stephen Hinshaw is a psychology professor at UC Berkeley and UC San Francisco. He led the largest long-term study of girls with ADHD, rewriting what we know about women's ADHD and why it matters right now. www.hinshawlab.berkeley.edu   Books by Dr. Hinshaw The Triple Bind: Saving Our Teenage Girls from Today's Pressures and Conflicting Expectations - https://www.amazon.ca/Triple-Bind-Pressures-Conflicting-Expectations/dp/0345504003 The ADHD Explosion: Myths, Medication, Money, and Today's Push for Performance - https://www.amazon.ca/ADHD-Explosion-Medication-Todays-Performance/dp/0199790558/ref=tmm_hrd_swatch_0   ABOUT THIS EPISODE The Impulsive Thinker® sits down with Dr. Stephen Hinshaw to break down the real ADHD experience for neurodivergent women and Entrepreneurs. Hear why most research ignored girls and what that cost in missed diagnoses, shame, and chaos. The episode digs into masking, self-injury, unplanned life consequences, and why classic ADHD stereotypes hurt more than help. Resilience, masking, and entrepreneurial strengths are redefined — no fluff, just blunt reality. This is for ADHD Entrepreneurs sick of society's measuring stick and shallow advice. If your chaos was survival, not failure — hit play. Email me about it at andre@theimpulsivethinker.com. Remember — ADHD failure is measured on society's measuring stick. Not yours. Your brain runs on interest, not importance. That's not a flaw. That's a different operating system. ADHD is not a deficit. It's a difference.  

Dr. Kahn highlights coronary calcium scoring, AI-enhanced CT angiography, and the TRANSFORM study's promise. #HeartScreening #CACScore #AIinMedicine #CardiacImaging

Gugs Mhlungu speaks to Dr Fundile Nyati, Resident GP and CEO of Proactive Health Solution, about the progress in autism diagnosis and improved screening processes, government’s role in subsidising treatment and expanding access to care and medication at a lower cost for those who cannot afford it. Gugs Mhlungu gets you ready for the weekend each Saturday and Sunday morning on 702. She is your weekend wake-up companion, with all you need to know for your weekend. The topics Gugs covers range from lifestyle, family, health, and fitness to books, motoring, cooking, culture, and what is happening on the weekend in 702land. Thank you for listening to a podcast from 702 Weekend Breakfast with Gugs Mhlungu. Listen live on Primedia+ on Saturdays and Sundays from 06:00 and 10:00 (SA Time) to Weekend Breakfast with Gugs Mhlungu broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/u3Sf7Zy or find all the catch-up podcasts here https://buff.ly/BIXS7AL Subscribe to the 702 daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Dr. Steven Storage is a child, adolescent, and adult psychiatrist at Amen Clinics, where brain SPECT imaging is used to diagnose and treat conditions like ADHD at the neurological level. In this episode, he and Karena cover the four pillars of brain health, how social media hijacks your dopamine, why ADHD is both genetic and environmental, the seven subtypes of ADHD, what low dopamine actually feels like, and a simple cognitive technique to stop negative thoughts from running your day. What happens to your focus, your mood, and your sense of self when your brain isn't getting what it needs — and how do you even know? Dr. Storage breaks down the neuroscience in a way that's impossible to unhear, from why one bad night of sleep costs you 30% of your executive function to how your social media habit may be draining the same brain chemical you need to feel motivated. This is the brain health conversation that has been missing from the wellness space. (00:38) The Four Pillars of Brain Health Sleep, exercise, nutrition, and avoiding toxins — the foundation for a functioning brain 20 minutes of higher-intensity cardio every other day shown to be as powerful as antidepressant medication for the brain What the brain is actually doing while you sleep  Food is fuel or garbage — why refined sugar and processed foods are inflammatory for the brain (07:07) Social Media, Dopamine & the Addiction Loop Social media is engineered to produce a dopamine spike, and the crash after is real Doom scrolling depletes the same chemical needed for focus, motivation, and productivity Why students who decompress with video games before homework are setting themselves up to struggle (11:59) ADHD Explained — Genetics, Perimenopause & What's Really Happening ADHD is one of the most genetic conditions in psychiatry ADHD as a supply-demand issue: blood flow to the prefrontal cortex vs. the demands placed on it Why perimenopause triggers ADHD-like symptoms  The difference between brain fog from perimenopause and preexisting ADHD — and why one makes the other worse (21:04) ADHD as a Superpower — And Why Medication Isn't the Enemy Why traits coded as ADHD likely survived evolution  Creativity, hyper-focus, intuition, outside-the-box thinking — the real strengths of an ADHD brain The mismatch between ADHD wiring and traditional classrooms: why Dr. Storage doesn't view ADHD as a disorder Stimulants vs. non-stimulants — what Adderall actually does to the prefrontal cortex The goal isn't to eliminate the superpower — it's to modulate the brain so you can access focus when you need it without losing creativity (32:35) Brain Development, Early Diagnosis & Rewiring Negative Thoughts The prefrontal cortex isn't fully developed until mid-to-late 20s — so how do you know when to treat? New MRI data: kids treated for ADHD before age 12 showed accelerated prefrontal cortex development Dr. Storage's three-step method for negative thought patterns Why meditation builds metacognitive awareness and helps thoughts pass like luggage on a conveyor belt Thanks for the support from our partners, including:  Guest Resources Follow Dr. Steven Storage on Instagram (https://www.instagram.com/drstevenstorage/) Follow Dr. Steven Storage on TikTok (https://www.tiktok.com/discover/dr-steven-storage) Visit Amen Clinics (https://www.amenclinics.com) If this episode moved you, please consider supporting The Big Silence Foundation and exploring our resources: Connect with The Big Silence Community Order: The Big Silence Memoir audiobook (https://thebigsilence.com/pages/audiobook) Shop The Big Silence Self Love Collection (https://thebigsilence.com/collections/shop-all) Subscribe on YouTube (https://www.youtube.com/channel/UCaL3RrbvDLuTTGFN4VYzEpw) Donate to The Big Silence Foundation (https://thebigsilence.com/donate) The Big Silence Resource Guide (https://thebigsilence.com/pages/resources) Find exclusive offers from our supporters (https://thebigsilence.com/pages/our-podcast-partners)

Sunstone Health CEO Joshua Resnikoff joins Chris Lustrino to explain how Sunstone uses AI on healthcare claims data to proactively identify children with developmental delay—starting with epilepsy and autism—and help families reach the right specialists and diagnostics faster.They break down what claims data is, why the healthcare system is reactive by default, and how Sunstone's approach can compress what often takes years into roughly weeks by flagging high-need cases, coordinating advanced diagnostics, and delivering actionable next steps. Joshua also shares Sunstone's go-to-market strategy (positioned as an employer-paid benefit), why the pricing model is designed to reduce “point-solution bloat,” and how expansion could move across employers, TPAs, reinsurers, and large insurers. 00:00 Needle-in-a-haystack intro03:13 What Sunstone does (AI + claims data)05:32 Flagging patients vs. diagnosing07:21 Employer benefit + privacy model15:54 GTM + sales cycle reality17:57 Outcome-based pricing model20:16 Unit economics ($10k per case)22:11 Expansion paths + other diseases26:23 Fundraise use of proceeds28:03 Investor closing

In this podcast, experts Mark Agulnik, MD; Sandra D'Angelo, MD; Mrinal M. Gounder, MD; and Sujana Movva, MD; discuss the complexities of diagnosing epithelioid sarcoma (ES) in a timely manner and the importance of multidisciplinary care in treating this disease at all stages.

In this episode of The Heart of Innovation, cohosts Kym McNicholas and Dr. John Phillips feature multiple patients courageously sharing their lived experiences with Peripheral Artery Disease, including rare and often misunderstood cases that challenge what patients are told is "possible." Pamela's story highlights a critical gap in PAD care. After being told by a large hospital system that amputation was inevitable, she reached out to the Global PAD Association's Leg Saver Hotline. Through patient advocacy and care coordination, the underlying contributors to her disease were identified, including the role climate played in worsening her symptoms. Her decision to relocate to a warmer environment helped stabilize her condition and avoid limb loss, proving that earlier intervention and individualized care matter. Francine's journey offers another rare perspective. Diagnosed at just 48 despite being a runner, personal trainer, and fitness instructor, she was found to have a full occlusion in her left leg and intermittent blockages in her right. After undergoing a femoral-popliteal bypass, multiple stents, and angioplasty procedures, Francine transformed her lifestyle through the Dean Ornish program and a low-fat vegan diet. She has since completed four half marathons and continues teaching group fitness, yoga, and Reiki. Theresa's story exposes how often PAD is dismissed, even when the warning signs are clear. With a family history of PAD, Theresa recognized the symptoms early. At 46, she sought help after developing walking pain, only to be told repeatedly that it was a back problem and that she was "too young" to have PAD. A Doppler study was performed but interpreted as normal. For five years, as her symptoms worsened and her walking distance shrank to less than ten metres, she continued to advocate for herself before finally insisting on a vascular referral. Within minutes of meeting a vascular consultant, Theresa was diagnosed with severe PAD. Imaging revealed a 100 percent blockage in her right leg and 80 percent in her left. Angioplasty provided temporary relief, but restenosis occurred quickly. A second procedure resulted in arterial injury, requiring placement of a 30-centimetre stent in her right thigh. Despite ongoing pain, Theresa developed remarkable collateral circulation, so robust that it complicated intervention attempts. Today, she remains closely monitored by a responsive vascular specialist and manages her condition with vigilance, pacing, and rest. She also notes a meaningful improvement in walking pain after starting Wegovy, an observation she continues to discuss with her care team. Equally important, Theresa speaks candidly about the emotional toll of PAD. A special education teacher who loves to travel, she feared the disease would take away the life she loved, as it had for her father. After a period of isolation, she made a conscious decision that PAD would be part of her story, but not the author of it. She now works full time, travels when she can, adapts when needed, and lives by a powerful truth: she controls PAD, not the other way around. Together, these stories reinforce a message too many patients never hear in time: Leg pain, cramping, and difficulty walking are not normal aging. They are warnings.

Pediatrician Yair Bannett studies and treats ADHD in preschool-age children. His interests stem from watching too many families struggle to understand their child's behavior. He now focuses on improving frontline care using artificial intelligence to analyze electronic health records. One recent study explored whether doctors are making appropriate non-drug interventions before choosing to medicate children. Through his research, he hopes to raise the standard of ADHD care for thousands – and perhaps millions – of children. Early diagnosis and better care can prevent later problems, Bannett tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Episode Reference Links:Stanford Profile: ​​Yair Bannett Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest Yair Bannett, a developmental behavioral pediatrician at Stanford University.(00:03:44) Why Study ADHDYair's path from primary care pediatrics to ADHD research.(00:04:32) Understanding ADHDThe core symptoms and diagnostic criteria for ADHD.(00:05:57) Diagnosing ADHD in YouthWhy diagnosis is challenging and relies on clinical judgment.(00:08:21) Known Causes of ADHDWhat is known about biological origins and environmental influence.(00:10:08) Geographic and Cultural DifferencesThe variations in ADHD prevalence across regions and populations.(00:11:37) ADHD Across CountriesPrevalence of ADHD globally and challenges with monitoring diagnosis.(00:12:23) Natural History of Untreated ADHDThe lifelong persistence of ADHD and associated risks when untreated.(00:14:28) ADHD Diagnosis in AdultsThe challenges in identifying and diagnosing ADHD later in life.(00:16:27) ADHD TreatmentsAn overview of the two treatment interventions used to treat ADHD.(00:18:16) Stimulant MedicationsThe effectiveness and long-term benefits of stimulant treatments.(00:21:30) Non-Stimulant MedicationsWhen and why alternative medications for ADHD are used.(00:22:31) Non-pharmacological InterventionsThe alternative interventions used outside pharmacological treatments.(00:23:18) Reducing Household ChaosStrategies for structure and behavior management within the home.(00:24:55) Measuring Quality of ADHD CareUsing electronic health records and AI to improve treatment.(00:28:10) Importance of Early DiagnosisThe benefits of identifying ADHD before school entry.(00:29:29) Future In a MinuteRapid-fire Q&A: applying AI, collaboration, and theatre dreams.(00:31:55) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of Autism for Badass Moms, host Rashidahwelcomes Meagan, a special education teacher and mother of an autistic daughter, to share her family's journey with neurodivergence. They discuss the importance of early autism diagnosis, Meagan's personal and professionalexperience navigating the educational system and how understanding her own neurodivergence has impacted her life. Meagan also talks about her nonprofit, Love Over Labels Advocacy, which focuses on IEP support, community outreach,and training law enforcement to better understand disabilities. This episode highlights the value of self-discovery, understanding neurodivergent traits, and fostering supportive communities for autistic individuals and their families. In this episode, we talk about:00:00 Introduction to Autism for Badass Moms00:43 Meet Megan: A Neurodivergent Mom's Journey01:25 Early Diagnosis and Family Realizations03:55 Navigating the Education System05:23 Challenges and Emotional Struggles07:03 The Importance of Community and Support08:57 Balancing Family Dynamics20:54 Advocacy and Nonprofit Work26:10 Innovative Teaching Approaches30:32 Challenges in Psychiatric Emergency Rooms31:30 Transformative Urgent Care Experience32:34 AAC Boards in Parks Initiative37:17 Love Over Labels: IEP Advocacy and Community Outreach38:32 Blue Envelope Program for Police Interactions44:49 Managing ADHD and Personal Well-being50:09 Encouragement for Moms Seeking Diagnosis55:21 Conclusion and Call to ActionConnect with Meagan:Website: Love Over Labels Advocacy | special needs advocacyInstagram:https://www.instagram.com/loveoverlabelsadvocacyhttps://www.instagram.com/meaganadvocates Facebook:https://www.facebook.com/loveoverlabels Threads:https://www.threads.com/@loveoverlabelsadvocacy If this episode resonated with you:Instagram: www.instagram.com/theabmpodcastFacebook: www.facebook.com/theabmpodcastTik Tok: autismforbadassmomsYouTube: autismforbadassmoms

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. CME/EBAC/AAPA/IPCE credit will be available until November 21, 2026.Nuclear Medicine for Alzheimer's Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. CME/EBAC/AAPA/IPCE credit will be available until November 21, 2026.Nuclear Medicine for Alzheimer's Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. CME/EBAC/AAPA/IPCE credit will be available until November 21, 2026.Nuclear Medicine for Alzheimer's Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. CME/EBAC/AAPA/IPCE credit will be available until November 21, 2026.Nuclear Medicine for Alzheimer's Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. CME/EBAC/AAPA/IPCE credit will be available until November 21, 2026.Nuclear Medicine for Alzheimer's Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. CME/EBAC/AAPA/IPCE credit will be available until November 21, 2026.Nuclear Medicine for Alzheimer's Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

In this enlightening episode, host Dr. Laura Scherck Wittcoff talks with Christine Buckley, the Executive Director and Board President of the Brain Aneurysm Foundation. The episode delves into the complexities and risks associated with brain aneurysms, highlighting the critical nature of early diagnosis and proper treatment. **Key Discussion Points:** 1. **Understanding Brain Aneurysms:** - The brain's intricate role as an organ and the devastating impacts when an aneurysm occurs. - Statistical insights into the prevalence and rupture rates of brain aneurysms. 2. **Personal Stories and Advocacy:** - Christine shares touching personal stories of individuals affected by brain aneurysms, emphasizing the unpredictability and severity of the condition. - The importance of self-advocacy in healthcare. 3. **Advancements in Treatment:** - How modern advancements have made treatments less invasive and more efficient. - The ongoing challenge of misdiagnosis and delayed treatment. 4. **Foundation Initiatives:** - The Brain Aneurysm Foundation's role in research, advocacy, and education. - The "Scan to Save" initiative is designed to improve early detection and healthcare provider education. 5. **Impact of Education and Awareness:** - Strategies to increase awareness and understanding of brain aneurysms among the public and healthcare professionals. - The importance of sharing information through social media and community outreach. 6. **Challenges and Future Goals:** - The need for more widespread awareness and support to prevent rupture-related fatalities and disabilities. - Christine's vision for a world free from the dangers of brain aneurysms and the continuous effort to secure research funding. **Call to Action:** Listeners are encouraged to share the podcast episode, follow the Brain Aneurysm Foundation on social media, and help spread awareness about the signs, symptoms, and importance of early detection of brain aneurysms. **Links and Resources:** - [Brain Aneurysm Foundation Website](www.bafound.org) - Social Media: [Facebook](www.facebook.com/bafound), [X](x.com/BAFOUND), [Instagram](www.instagram.com/bafound), [LinkedIn] (www.linkedin.com/company/the-brain-aneurysm-foundation) [YouTube](www.youtube.com/user/brainaneurysmfound For more Small & Gutsy episodes: https://smallandgutsy.org/episodes/

When Stacey's toddler was diagnosed with Type 1 diabetes, her family's world turned upside down. In this episode, she shares the early warning signs, the struggle of those first two weeks of injections, and how humor and community turned fear into resilience. Parents will gain hope, advocacy tips, and coping strategies for managing a chronic illness diagnosis.  What You'll Hear How Stacey recognized the 4 Ts of diabetes: Thirsty, Tired, Thinner, Toilet The reality of hospitalization, finger sticks, and injections with a toddler Coping strategies: medical play, humor, and routines that work The power of community and rejecting “perfect parenting” Building advocacy through Diabetes Connections and The World's Worst Diabetes Mom About Stacey Stacey Simms is an award-winning broadcaster, speaker, and author of The World's Worst Diabetes Mom. Since 2015, she has hosted Diabetes Connections, offering real stories and resources for the Type 1 community.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

When her husband was diagnosed with frontotemporal degeneration at just 29, Katie Brandt's life changed overnight. What began as confusion and heartbreak became a lifelong calling to transform how we see, support, and study dementia. Today, Katie is the Director of Caregiver Support Services and Public Relations at the Massachusetts General Hospital Frontotemporal Disorders Unit, and the Founder & CEO of Katie Brandt Advocacy. In this conversation, we talk about what it means to become a “caregiver detective”, the quiet observer, the record keeper, the advocate who pieces together the truth when something feels off. We explore how early and accurate diagnosis brings dignity, how research becomes more human when it includes caregiver voices, and why supporting caregivers isn't just compassionate, it's strategic. Katie shares the lessons she's learned through love, loss, and leadership, and how her belief that “love will end FTD” continues to guide her work and the families she serves.   To buys tickets and learn more about A Night with the Arts for FTD, an annual gala featuring the Sermos Memorial Art Show, benefitting the clinical research program in the MGH Frontotemporal Disorders Unit. Visit HERE. The MGH Frontotemporal Disorders Unit hosts From Care to Cure podcast. Listen HERE. Thank you to our Sponsor Zinnia TV is a therapeutic dementia care platform that supports caregivers. We are not medical professionals and are not providing any medical advice. If you have any medical questions, we recommend that you talk with a medical professional of your choice. willGather has taken care in selecting its speakers but the opinions of our speakers are theirs alone. Thank you for your continued interest in our podcasts. Please follow for updates, rate & review! For more information about our guest, podcast & sponsorship opportunities, visit www.willgatherpodcast.com

Dr. Hoffman continues his conversation with Nicole Bell, the CEO of Galaxy Diagnostics and author of “What Lurks in the Woods.” 

This episode of the Intelligent Medicine podcast is a deep dive into the complexities of Lyme disease and other tick-borne illnesses. Nicole Bell, the CEO of Galaxy Diagnostics and author of “What Lurks in the Woods,” details the challenges of diagnosing tick-borne diseases, the limitations of current diagnostic tests, and the controversy around treatment methodologies. Nicole shares her personal journey that led her to this field after her husband was misdiagnosed with early-onset Alzheimer's, which was later revealed to be caused by advanced Lyme disease. They also discuss new diagnostic techniques, the importance of personalized treatment plans, and ongoing advocacy efforts to improve awareness and research funding for Lyme disease.

This week, Bobbi Conner talks with MUSC's Dr. Sarah Breevoort about early diagnosis and treatment for ALS (Lou Gehrig's disease).

On The Down Low – Season 2: it's time to start talking about uterine cancersThe body often whispers before it screams — and recognising those early whispers can save lives. In this episode, we explore the importance of listening to symptoms like abnormal bleeding, and the role of risk factors such as obesity, hormones, lifestyle, and genetic predispositions including Lynch Syndrome. Through lived experience stories from Carly and Ruth, and expert insights from Professor Alison Brand AM, we uncover how prevention, risk assessment, and early diagnosis can change the future of uterine cancers.Know someone who needs to hear this? Share it, talk about it, and help break the silence around uterine cancers.Season 2 was produced by ANZGOG, with the generous support of GSK and Eisai.

Can your crops really talk?   On this episode of The Dirt, host Mike Howell sits down with Co-Founder and Director of Vivent Biosignals, Nigel Wallbridge, to uncover how biosensors are helping farmers tap into the hidden communication networks inside their plants.   Nigel shares how tiny electrodes and AI algorithms work together to detect internal crop signals before they are visible in the field.   From early warnings of drought, disease, and nutrient deficiencies to real-time insights that improve irrigation and soil fertility planning, this technology is giving farmers a new way to "listen" to their crops. Tune in to explore the benefits of biosensors, what they can detect, and how you can implement them on your operation.   To learn more about biosensors and the new technology offered by Vivent, visit www.vivent-biosignals.com   Looking for the latest in crop nutrition research? Visit nutrien-ekonomics.com   Subscribe to our YouTube channel: https://www.youtube.com/@NutrieneKonomics          

Send us a textCan what your child eats really affect their behavior?In this episode of the Mother's Guide Through Autism podcast, Brigitte speaks with Sonya Bell—a registered nurse, autism mom, and integrative nutrition health coach—about the powerful connection between food and behavior in neurodivergent children.After both her son and daughter were diagnosed with developmental differences, Sonya began exploring the role of nutrition. From removing food additives to embracing whole, clean eating, Sonya shares the steps that helped her son thrive emotionally and behaviorally—and how you can begin making changes too.You'll also hear about her inspiring book Moving Forward: Details of an Autism Journey, and the importance of hope, self-care, and community support on this path.

Alzheimer's Disease Early Diagnosis and Management Evaluation and Credit:  https://www.surveymonkey.com/r/medchat82   Target Audience             This activity is targeted toward primary care physicians and advanced providers. Statement of Need A special report of Alzheimer's Disease Facts and Figures published in 2017, indicated 4 out of 5 Americans would want to know if they had Alzheimer's disease before it impacted their life. With the aging population the incidence of Alzheimer's is growing, according to the Alzheimer's Association over 7 million Americans are living with AD. This program will focus on screening and dx of AD in the early stages especially in pc offices, where patients will first present with cognitive symptoms. Additionally, this podcast will highlight the new blood biomarker test recently approved and its indications. Objectives  Differentiate between normal cognitive aging, mild cognitive impairment and early-stage Alzheimer's disease. Identify appropriate cognitive screening tools for use in primary care and their role in the early identification of Alzheimer's disease. Explain the mechanism and clinical relevance of blood-based biomarkers in the diagnosis of Alzheimer's disease, including the current guidelines and emerging practices. ModeratorRachel Hart, D.O. Geriatric Medicine Physician Memory and Cognitive Disorders Specialist Norton Neuroscience Institute Memory Center SpeakerGreg E. Cooper, M.D., Ph.D. Chief, Adult Neurology Medical Director, Memory Center Norton Neuroscience Institute   Planner Disclosure  The planners of this activity do not have any relevant financial relationships with ineligible companies to disclose. Moderator and Speaker DisclosureThe moderator, Gregory Cooper, M.D., Ph.D., discloses relevant financial relationships with Eli Lilly and Eisai (research). The speaker, Rachel Hart, D.O., discloses a relevant financial relationship with Eli Lilly (faculty).  All relevant financial relationships have been successfully mitigated. Commercial Support  There was no commercial support for this activity.  Physician CreditsAccreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Credits Norton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.50 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.   For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org.   Resources for Additional Study/ReferencesAmerican Perspectives on Early Detection of Alzheimer's Disease in the Era of Treatment https://www.alz.org/alzheimers-dementia/facts-figures   Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care https://pubmed.ncbi.nlm.nih.gov/39068545/   Date of Original Release | Sept. 2025; Information is current as of the time of recording.  Course Termination Date | Sept. 2028 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.

In this inspiring episode of The Better Life with Dr. Pinkston, I welcome Tiffany Jones Smith—President of the Texas Kidney Foundation, Chair of the Chronic Kidney Disease Task Force, the first African American woman to hold these positions, and a chronic kidney disease patient herself. Tiffany shares her powerful journey and groundbreaking leadership, highlighting the urgent need for awareness, early diagnosis, and patient advocacy in kidney health. Together, we explore how patients can take an active role in their care and how hope and action can change the future of chronic kidney disease.See omnystudio.com/listener for privacy information.

Lisa and Tess dive into the importance of proactive health advocacy, the confusion and lack of information many women face around screenings, and the power of forming intentional daily habits for long-term wellness. Tess shares her personal journey of discovering she had dense breast tissue, the challenges she faced in getting the right screenings, and how self-education and persistence played crucial roles in her health journey. Together, they discuss the importance of early detection, how lifestyle choices such as movement, nutrition, and restorative sleep contribute to overall health, and why building a supportive community makes all the difference. Whether you're navigating your own diagnosis, supporting a loved one, or simply passionate about women's health, this episode offers inspiration, practical tips, and that vital push to be your own advocate. Join us as we shine a light on women's health, break down barriers to information, and remind listeners of the power found in sharing our stories.   TIMESTAMPS: 00:00 "Amplifying Women's Voices on Health" 06:24 Dense Breast Tissue Guidance Insights 08:29 Dual Scans Essential for Accuracy 13:12 Improving Life with Early Diagnosis 15:38 Wine, Heart Health, and Breast Cancer 20:15 Improving Sleep with Night Routine 22:25 "Evening Eating Affects Sleep Quality" 25:47 Overwhelmed Professionals Seek Health Guidance 28:27 Dense Breast Tissue: Be Proactive   LEARN MORE: The Clear Pathways Program, Walk, Summit, App and Initiative powered by For The Love Of Cups - Join our task force or advisory board. https://www.breastdensitysummit.org/   Tess Cheng, a certified health and wellness coach with over 13 years of experience, is dedicated to helping individuals achieve lasting success through sustainable wellness practices. Having navigated her own journey with hypoglycemia and a family history of diabetes, Tess advocates for holistic lifestyle changes that foster both personal and professional growth. With a Master's degree in Clinical Nutrition from NYU, Tess combines practical strategies focused on mindset, self-care, disease prevention, and longevity. She believes that prioritizing wellness not only enhances daily health but also lays the foundation for long-term vitality and success in all areas of life.   Follow Tess: https://glowithtess.com/ http://linkedin.com/in/tess-cheng-ms https://www.instagram.com/glowithtess/ https://www.facebook.com/Glowithtess   #wellness #habits #breasthealth #breastscreening #breastcancer #womenshealth #womeninwellness #femtech #breastdensity   

"Can early detection and community support improve COPD care?" In the final part of this episode, Dr. Olli Tikkanen speaks with David Mannino, MD, Jonnie Korinko, and Phyllis DiLorenzo about the critical role of early diagnosis, effective treatment, and community support for COPD patients. Mannino, MD discusses the latest research efforts to detect COPD in its early stages, before symptoms worsen. Jonnie Korinko emphasizes the importance of pulmonary rehabilitation programs, not only for physical activity but also for medication education and patient empowerment. Phyllis DiLorenzo shares her own experiences, highlighting the vital support networks available to COPD patients and how peer connections have made a meaningful impact on her journey. The guests also explore the challenges of reimbursement and access to pulmonary rehab, stressing the need for broader support and awareness to improve COPD care. This episode provides an in-depth look at the essential components of COPD management and offers valuable insights for anyone interested in respiratory health and patient advocacy. ___________________   This podcast episode is sponsored by Fibion Inc. | Better Sleep, Sedentary Behavior and Physical Activity Research with Less Hassle --- Collect, store and manage SB and PA data easily and remotely - Discover ground-breaking Fibion SENS. --- SB and PA measurements, analysis, and feedback made easy - Learn more about Fibion Research. --- Learn more about Fibion Sleep and Fibion Circadian Rhythm Solutions. --- Fibion Kids - Activity tracking designed for children. --- Explore our Wearables,  Experience sampling method (ESM), Sleep,  Heart rate variability (HRV), Sedentary Behavior and Physical Activity article collections for insights on related articles. --- Refer to our article "Physical Activity and Sedentary Behavior Measurements" for an exploration of active and sedentary lifestyle assessment methods. --- Learn about actigraphy in our guide: Exploring Actigraphy in Scientific Research: A Comprehensive Guide. --- Gain foundational ESM insights with "Introduction to Experience Sampling Method (ESM)" for a comprehensive overview. --- Explore accelerometer use in health research with our article "Measuring Physical Activity and Sedentary Behavior with Accelerometers ". --- For an introduction to the fundamental aspects of HRV, consider revisiting our Ultimate Guide to Heart Rate Variability. --- Follow the podcast on Twitter https://twitter.com/PA_Researcher  Follow host Dr Olli Tikkanen on Twitter https://twitter.com/ollitikkanen  Follow Fibion on Twitter https://twitter.com/fibion  Check us on YouTube: https://www.youtube.com/@PA_Researcher 

Dr. Erin Michaud, SLP and BCBA-D with over 20 years of experience in communication development and ABA, joins the podcast to share the groundbreaking work of The Early Markers of Autism Project—a program changing the landscape of early autism identification and intervention.This hands-on, in-person research and treatment study works with infants from both high-risk populations (siblings of children with autism, with a 20% recurrence rate) and low-risk populations. By tracking social interaction, shifting attention, joint attention, and social behaviors from infancy through age five, the project identifies and responds to early markers far earlier than the current AAP screening recommendation of 18 months.The impact? Earlier diagnoses, earlier interventions, and fewer families waiting for services. Dr. Michaud shares how this project is creating validated assessment tools, expanding parent training, and building strong research to push for insurance coverage—bringing meaningful change for high-risk infants and their families.#autism #speechtherapyWhat's Inside:What are the early markers of autism?What is the Autism Sibling Project?Supporting parents and our littlest learners.Mentioned In This Episode:Talking First Words — Coming Soon ​​Early Markers of Autism Project | The New England Center for Children7 Investigates: Autism Intervention - Boston News, Weather, Sports | WHDH 7NewsNECC Infant Sibling Research Project 2023 Speech Membership - ABA Speech  ABA Speech: HomeThe BriefAll your family's pressing concerns and questions, answered in one place. Mike...Listen on: Apple Podcasts Spotify

Can you detect Alzheimer's with a spit sample? That's the question driving Arianna Arbona's exciting research at Universidad Pablo de Olavide in Sevilla, Spain. In this episode of Absolute Gene-ius, she shares how she's isolating microvesicles from saliva and blood to identify early biomarkers for neurodegenerative diseases like Alzheimer's—an effort that could one day lead to minimally invasive diagnostic tools.Arianna describes the scientific and technical hurdles she's overcoming, from low vesicle concentrations to validating the brain-specific origin of those vesicles. She also reflects on her previous lupus research, where digital PCR enabled detection of faint mRNA signatures that qPCR missed—making it an essential tool for rare target quantification. Her future plans include integrating immuno-PCR and multiplex assays for more sensitive and multi-marker detection in Alzheimer's and beyond.In the career corner, Arianna recounts her journey from the Canary Islands to Helsinki to Sevilla, balancing passion, mentorship, and a healthy sense of humor. She talks about working through uncertainty after her master's degree, the mentors who kept her smiling, and how an early accidents taught her resilience. Her message to aspiring scientists: follow your curiosity and don't be afraid to change direction.Visit the Absolute Gene-ius pageto learn more about the guests, the hosts, and the Applied Biosystems QuantStudio Absolute Q Digital PCR System. 

Sarcoma is rare but the need for awareness is urgent. This lesser-known group of cancers often goes undetected until it's advanced, making early diagnosis difficult and treatment more complex. In our latest episode, we're shedding light on what sarcoma is, the early warning signs, the hurdles in diagnosis, and the progress in research that's giving patients better options and hope.If you're in healthcare, patient advocacy, or simply want to be more informed, this conversation matters. Listen, share, and help amplify the message. Only on TALRadio English.Host : MadhaviExpert : Kaumudi Bhawe#TALRadioEnglish #SarcomaAwareness #CancerAwareness #HealthEducation #Oncology #RareCancer #PatientSupport #EarlyDetection #CancerCare #HealthcareProfessionals #PublicHealth #MedicalResearch #TouchALife #TALRadio

Chronic kidney disease, or CKD, is the most common cause of death in senior…

Chronic kidney disease, or CKD, is the most common cause of death in senior cats. Unfortunately, it's usually not diagnosed until symptoms are advanced. But when it's caught early, targeted...

We dive deep into the real world impact of leg length discrepancy (LLD) with two athletes - one who corrected it, and one who's considering the journey.⚽ Sam, a former semi-pro soccer player, shares how a 2.3cm congenital tibial discrepancy affected his mobility and performance. After undergoing tibial lengthening surgery, he's now able to run, perform agility, do marathons and play with his son without pain and plans to compete in a soccer tournament this fall - he shares everything about the recovery, rehab, and mental shift that came with it.

On the "Sound of Ideas" we will talk to several people living with ADHD, and a doctor who works in diagnosis and treatment.

In today's episode, we dive into the wonders of T-cell immunology technology and how it impacts early treatment interventions with long-time drug developer Dr. Nigel McCracken. As the Chief Operating Officer of Virax Biolabs, Dr. McCracken has more than 25 years of research and development experience in this diverse field – including oncology and infectious disease… Virax Biolabs is committed to revolutionizing global health by accelerating the development of more effective vaccines. How do they achieve this? By harnessing cutting-edge diagnostics to power a groundbreaking T-cell immunology platform, enabling early detection of post-viral syndromes and conditions linked to chronic inflammation and T-cell exhaustion. Before joining Virax, Dr. McCracken served as Chief Scientific Officer at BerGenBio ASA, where he led the development of companion diagnostics and assay strategies. Prior to that, he was COO at NuCana PLC, a clinical-stage biopharmaceutical company dedicated to improving cancer treatment outcomes. In this role, he oversaw business operations, research and development, and the execution of corporate strategy. Tune in now to learn about: The importance of early diagnosis when it comes to immune system dysfunction. How the complementary system interacts with the immune system.  The typical role that T-cells play in infections.  Why chronic health problems are on the rise, and what this could mean for the future of healthcare. You can follow along with Dr. McCracken's work at Virax Biolabs here! Episode also available on Apple Podcasts: https://apple.co/30PvU9C Upgrade Your Wallet Game with Ekster!  Get the sleek, smart wallet you deserve—and save while you're at it! Use coupon code FINDINGGENIUS at checkout or shop now with this exclusive link: ekster.com?sca_ref=4822922.DtoeXHFUmQ5  Smarter, slimmer, better. Don't miss out!